Porton Pharma and Aojin Life Sciences Form Strategic Partnership
Recently, Porton Pharma Solutions Ltd. ("Porton") announced a strategic partnership with Aojin Life …
Porton Recognized for Sustainable Development in China 2024
Porton was recently selected as a "2024 Exemplary Case for Sustainable Development Among Chinese Lis…
Porton Pharma Solutions Launches Newly Redesigned Official Website
With a Focus on Globalization, Innovative Technology Platforms, and Accelerating Your New Business O…
Porton Attends China-Slovenia Business Forum and Meets Officials
During the Slovenian government delegation's visit to Shanghai, the Slovenian Consulate in Shanghai …
Ceremony Marks Porton’s New Modality Capacity Upgrade
On November 7, 2024, the New Modality Capacity Upgrade Ceremony was successfully held in Fengxian,...
Enhanced GMP Manufacturing and Services at Porton Fengxian, Shanghai
Recently, Porton Pharma has achieved a significant capacity breakthrough at its GMP manufacturing fa…
Porton Pharma and Shanghai InnoStar Forge Strategic Partnership
On October 24, 2024, Porton Pharma SolutionsLtd. ("Porton") announced a strategic partnership with S…
Porton Pharma Solutions: Innovation in CDMO at CPHI Europe 2024
Recently, the three-day 2024 CPHI Milan exhibition concluded successfully in Milan, Italy. As a lead…
Meet Porton J-STAR at AAPS PharmSci 360 2024, Booth 2431!
The AAPS PharmSci 360, held from October 20-23, 2024, is an eminent event in the...